No one likes getting injections -- we all wish for those hyposprays from Star Trek, where one little puff takes care of all your medicinal needs, painlessly. Well, we're not quite there yet, but Cambridge Consultants has just announced the Conix One, a new type of inhaler that it claims costs less to manufacture than a single syringe. The company's press release says that its "reverse flow cyclone" provides an "extremely effective deagglomeration process" (just what we've been looking for!), apparently meaning that you can absorb the drug into your lungs faster. If that bird flu does hit, we'll be stocking these faster than you can say "H5N1."

0 Comments

Conix One, a new four-cent inhaler that may save the world